Artia Global Partners »

Praxis Precision Medicines I shares owned by Artia Global Partners

Quarter-by-quarter ownership of Praxis Precision Medicines I (PRAX) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Praxis Precision Medicines I

Tip: Access up to 7 years of quarterly data

All positions including Praxis Precision Medicines I held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Praxis Precision Medicines I by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $737k 2.5k 294.74

More positions owned by Artia Global Partners

Insmed Com Par $.01 (INSM)
Abivax Sa Sponsored Ads (ABVX)
Argenx Se Sponsored Adr (ARGX)
Eli Lilly & Co. (LLY)
Proshares Tr Ii Ultra Gold (UGL)
Soleno Therapeutics (SLNO)
Viking Therapeutics (VKTX)
Trevi Therapeutics (TRVI)
Uniqure Nv SHS (QURE)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Astrazeneca Sponsored Adr
Cidara Therapeutics Com New (CDTX)
Eyepoint Pharmaceuticals Com New (EYPT)
Ionis Pharmaceuticals (IONS)
Dianthus Therapeutics (DNTH)

View all positions for Artia Global Partners

Top funds holding Praxis Precision Medicines I

Henderson Group
Adage Capital Partners GP
BlackRock
Perceptive Advisors
Vanguard Group
Orbis Allan Gray
Point72 Asset Management
Cormorant Asset Management
Deerfield Management Company
State Street Corporation
Goldman Sachs Group
Baker Bros. Advisors
Geode Capital Management
Barclays
Driehaus Capital Management

View all funds holding Praxis Precision Medicines I